Our study suggested that AZD8055-mediated cervical cancer cell proliferation inhibition may occur through deregulating mTOR activity and upregulating the expression of miR-143, whose targets include HK2, a key time-limiting enzyme in the process of glucose activation. The gene discussed is MTOR; the disease is cervical cancer.